IMAX Imax (IMAX) Insider Trading, Ownership & Congress Trades
Consumer Goods · Photographic equipment & supplies · CIK 0000921582
Form 144 · 9
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
138
13F, latest reported quarter
Conversions, 180 days
10
Codes C/M, not in net · $11.4M priced
What the filings say about IMAX
Insiders, 180 days
-$29.1M net sold
7 sellers · 33% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$29.1M
9 notices
Imax insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, IMAX CORP insiders sold a net $29.1M of stock across 52 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Nov 7, 2025.
- The trade is 12.3% of the 182,375 shares held after it.
- 5 other insiders sold within 30 days.
- 138 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Sr Exec VP LISTER ROBERT D sold about $1.2M of IMAX on Sep 10, 2026; 5 other insiders sold within 30 days and 138 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Aug 14, 2025.
- The trade is 28.4% of the 28,205 shares held after it.
- 6 other insiders sold within 30 days.
- 138 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Deputy GC, Corp. Sec. & CCO Weissman Kenneth Ian sold about $436.3K of IMAX on Aug 25, 2026; 6 other insiders sold within 30 days and 138 funds added in the latest 13F quarter.Context
- 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Dec 15, 2025.
- The trade is 20.9% of the 143,216 shares held after it.
- 6 other insiders sold within 30 days.
- 138 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President IMAX Global Theatres WELTON MARK sold about $1.6M of IMAX on Aug 25, 2026; 6 other insiders sold within 30 days and 138 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Nov 24, 2025.
- The trade is 56.2% of the 35,596 shares held after it.
- 6 other insiders sold within 30 days.
- 138 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer & EVP Fernandes Natasha sold about $1.1M of IMAX on Aug 24, 2026; 6 other insiders sold within 30 days and 138 funds added in the latest 13F quarter.Context
- 14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on Aug 19, 2026.
- The trade is 15.0% of the 665,002 shares held after it.
- 6 other insiders sold within 30 days.
- 138 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer GELFOND RICHARD L sold about $5.3M of IMAX under a 10b5-1 plan on Aug 20, 2026; 6 other insiders sold within 30 days and 138 funds added in the latest 13F quarter.52 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$29.1M over 180 days
-$29.1M over 90 days
below 90% of Consumer Goods
Congress
no House purchase disclosed in the last 12 months
Funds
138 funds bought in last quarter
more than 60% of Consumer Goods
Revenue
+16.5% year over year
more than 78% of Consumer Goods
Margin
8.5% net margin
more than 80% of Consumer Goods
Buybacks
no share repurchases reported
Short interest
15.9% of the float short (float per yahoo 2026-10-26) · 6.3 days to cover · settled 2026-09-30
more than 93% of Consumer Goods
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch IMAX
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+66.5%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns IMAX: institutional holders (13F)
13F holdings, latest reported quarter
5,149,555 sh
$205.3M
2,936,661 sh
$117.1M
2,907,192 sh
$115.9M
2,654,014 sh
$105.8M
2,537,290 sh
$101.1M
Congress trades in IMAX
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
IMAX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Robert D. Lister
Filed 2026-09-10
$1.2M
KENNETH WEISSMAN
Filed 2026-08-25
$436.3K
MARK WELTON
Filed 2026-08-25
$1.6M
NATASHA FERNANDES
Filed 2026-08-24
$1.1M
Richard Gelfond
Filed 2026-08-20
$5.3M
IMAX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Congress Small Cap Growth Fund
$62.2M position · as of 2026-07-31
3.1%
Harbor Small Cap Growth Fund
$63.6M position · as of 2026-07-31
2.4%
Foreign Smaller Companies Series
$398.6K position · as of 2026-06-30
2.1%
Nationwide Renaissance Small Cap Growth Fund
$445.1K position · as of 2026-07-31
2.0%
AMG GW&K Small Cap Value Fund
$4.5M position · as of 2026-06-30
1.9%
Lord Abbett Micro-Cap Growth Fund
$3.9M position · as of 2026-07-31
1.8%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Richard L. Gelfond
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$8.7M
$21.5M
$2.3M
+105%
-34%
2024
$8.0M
$20.4M
$2.1M
+42%
-25%
2023
$8.7M
$9.4M
$2.3M
-17%
-29%
2022
$8.0M
$5.8M
$2.1M
-19%
+8%
2021
$9.1M
$9.6M
$2.6M
-1%
+32%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $29.1M sold by insiders over 180 days, 138 funds added last quarter, $29.1M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
IMAX financials
Revenue growth
+16.5%
XBRL, annual
Net margin
8.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$416.1M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM IMAX
| FY Dec 2025 | $410.2M |
| FY Dec 2024 | $352.2M |
| FY Dec 2023 | $374.8M |
| FY Dec 2022 | $300.8M |
| FY Dec 2021 | $254.9M |
| Jun 2026 | $102.8M |
| Mar 2026 | $81.4M |
| Dec 2025 | $125.2M |
| Sep 2025 | $106.7M |
| Jun 2025 | $91.7M |
| Mar 2025 | $86.7M |
| Dec 2024 | $92.7M |
| Sep 2024 | $91.5M |
At each fiscal year end
Single quarter
Net margin, TTM
+9.8%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM IMAX
| FY Dec 2025 | +8.5% |
| FY Dec 2024 | +7.4% |
| FY Dec 2023 | +6.7% |
| FY Dec 2022 | -7.6% |
| FY Dec 2021 | -8.7% |
| Jun 2026 | +15.0% |
| Mar 2026 | +5.2% |
| Dec 2025 | +0.5% |
| Sep 2025 | +19.4% |
| Jun 2025 | +12.3% |
| Mar 2025 | +2.7% |
| Dec 2024 | +5.8% |
| Sep 2024 | +15.2% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$126.6M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM IMAX
| FY Dec 2025 | $118.9M |
| FY Dec 2024 | $62.4M |
| FY Dec 2023 | $52.1M |
| FY Dec 2022 | $8.9M |
| FY Dec 2021 | $2.5M |
| Jun 2026 | $32.0M |
| Mar 2026 | $1.9M |
| Dec 2025 | $28.0M |
| Sep 2025 | $64.8M |
| Jun 2025 | $20.9M |
| Mar 2025 | $5.3M |
| Dec 2024 | $6.9M |
| Sep 2024 | $34.2M |
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term debt only, 2022-03-31 (51 months older than the period end); equity 2026-06-30
Debt to equity IMAX
| FY Dec 2025 | 0.00x |
| FY Dec 2024 | 0.00x |
| FY Dec 2023 | 0.00x |
| FY Dec 2022 | 0.00x |
| FY Dec 2021 | 0.01x |
| Jun 2026 | 0.00x |
| Mar 2026 | 0.00x |
| Dec 2025 | 0.00x |
| Sep 2025 | 0.00x |
| Jun 2025 | 0.00x |
| Mar 2025 | 0.00x |
| Dec 2024 | 0.00x |
| Sep 2024 | 0.00x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
123.06x
TTM operating cash flow over long-term debt only, 2022-03-31 (51 months older than the period end)
Cash flow to debt IMAX
| FY Dec 2025 | 117.66x |
| FY Dec 2024 | 65.59x |
| FY Dec 2023 | 54.27x |
| FY Dec 2022 | 16.04x |
| FY Dec 2021 | 2.45x |
| Jun 2026 | 123.06x |
| Mar 2026 | 114.95x |
| Dec 2025 | 117.66x |
| Sep 2025 | 101.09x |
| Jun 2025 | 71.25x |
| Mar 2025 | 82.18x |
| Dec 2024 | 65.59x |
| Sep 2024 | 58.67x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity IMAX
| FY Dec 2025 | +11.0% |
| FY Dec 2024 | +9.1% |
| FY Dec 2023 | +9.4% |
| FY Dec 2022 | -7.4% |
| FY Dec 2021 | -5.9% |
| Jun 2026 | +12.1% |
| Mar 2026 | +11.6% |
| Dec 2025 | +11.0% |
| Sep 2025 | +12.4% |
| Jun 2025 | +11.2% |
| Mar 2025 | +9.0% |
| Dec 2024 | +9.1% |
| Sep 2024 | +8.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets IMAX
| FY Dec 2025 | +4.0% |
| FY Dec 2024 | +3.2% |
| FY Dec 2023 | +3.1% |
| FY Dec 2022 | -2.7% |
| FY Dec 2021 | -2.4% |
| Jun 2026 | +4.6% |
| Mar 2026 | +4.2% |
| Dec 2025 | +4.0% |
| Sep 2025 | +4.6% |
| Jun 2025 | +3.9% |
| Mar 2025 | +3.0% |
| Dec 2024 | +3.2% |
| Sep 2024 | +2.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+31.0%
operating income after a 24.4% effective tax rate, over long-term debt only, 2022-03-31 (51 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital IMAX
| FY Dec 2025 | +31.2% |
| FY Dec 2024 | +19.1% |
| FY Dec 2023 | +19.8% |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | +31.0% |
| Mar 2026 | +30.3% |
| Dec 2025 | +31.2% |
| Sep 2025 | +27.1% |
| Jun 2025 | +23.9% |
| Mar 2025 | +21.1% |
| Dec 2024 | +19.1% |
| Sep 2024 | +19.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
assets or current liabilities not filed
Return on capital employed IMAX
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
74.14x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing IMAX
| FY Dec 2025 | 59.61x |
| FY Dec 2024 | 53.33x |
| FY Dec 2023 | 32.65x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 55.36x |
| Mar 2026 | 58.48x |
| Dec 2025 | 59.61x |
| Sep 2025 | 46.79x |
| Jun 2025 | 47.39x |
| Mar 2025 | 57.28x |
| Dec 2024 | 53.33x |
| Sep 2024 | 46.61x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.8B
market value at close 2026-10-23 on 2026-06-30 shares, plus long-term debt only, 2022-03-31 (51 months older than the period end), minus cash 2026-06-30
Enterprise value IMAX
| FY Dec 2025 | $1.8B |
| FY Dec 2024 | $1.2B |
| FY Dec 2023 | $745.1M |
| FY Dec 2022 | $724.2M |
| FY Dec 2021 | $866.8M |
| Jun 2026 | $2.0B |
| Mar 2026 | $1.9B |
| Dec 2025 | $1.8B |
| Sep 2025 | $1.6B |
| Jun 2025 | $1.4B |
| Mar 2025 | $1.3B |
| Dec 2024 | $1.2B |
| Sep 2024 | $977.1M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+4.3%
TTM free cash flow over market value at close 2026-10-23
FCF yield IMAX
| FY Dec 2025 | +6.0% |
| FY Dec 2024 | +4.6% |
| FY Dec 2023 | +6.4% |
| FY Dec 2022 | +1.1% |
| FY Dec 2021 | +0.2% |
| Jun 2026 | +5.8% |
| Mar 2026 | +5.5% |
| Dec 2025 | +6.0% |
| Sep 2025 | +5.6% |
| Jun 2025 | +4.5% |
| Mar 2025 | +5.6% |
| Dec 2024 | +4.6% |
| Sep 2024 | +5.1% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
3.36x
P/E over trailing EPS growth of 22%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing IMAX
| FY Dec 2025 | 2.04x |
| FY Dec 2024 | 12.27x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 2.51x |
| Mar 2026 | 1.42x |
| Dec 2025 | 2.04x |
| Sep 2025 | 0.79x |
| Jun 2025 | 1.00x |
| Mar 2025 | n/a |
| Dec 2024 | 12.27x |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $410.2M | $352.2M | $374.8M | $300.8M |
| Gross profit | $246.2M | $190.2M | $214.3M | $156.4M |
| Operating income | $84.2M | $43.9M | $50.4M | -$4.8M |
| Net income | $34.9M | $26.1M | $25.3M | -$22.8M |
| EPS (diluted) | 0.63 | 0.48 | 0.46 | -0.40 |
| Operating cash flow | $127.1M | $70.8M | $58.6M | $17.3M |
| Cash | $151.2M | $100.6M | $76.2M | $97.4M |
SEC XBRL, fiscal years, as known on 2026-10-27
IMAX Stock Sonar score 6/7 axes
Find similar shapesCompareIMAX ranks highest on financial health (93rd percentile) and profitability (68th), and lowest on insider conviction (11th), among Consumer Goods peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
IMAX filings, in plain words
Are Imax insiders buying or selling IMAX?
In the 180 days to 2026-10-27, Imax insiders were net sellers, a net $29.1M across purchases and sales reported on Form 4, by 7 sellers.
Are there planned insider sales of IMAX?
Yes. 9 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $29.1M of stock; the latest, by Robert D. Lister, was filed 2026-09-10.
Read the full summary
In the 180 days to 2026-10-27, Imax insiders were net sellers of IMAX, a net $29.1M across purchases and sales reported on Form 4 by 7 sellers. 33% of the 9 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 9 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $29.1M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
